6:08 PM
 | 
Feb 27, 2013
 |  BC Extra  |  Top Story

Araxes debuts with Janssen cancer deal

Newco Araxes Pharma LLC (San Diego, Calif.) partnered with the Janssen Biotech Inc. subsidiary of Johnson & Johnson (NYSE:JNJ) to discover and develop therapeutics against an undisclosed target to treat cancer. Araxes, which is...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >